Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Influenza Vaccine (VLP Therapeutics)
- Development stage
- Approved
- Lead developer
- VLP Therapeutics
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Influenza Vaccine (VLP Therapeutics) is an investigational virus-like particle (VLP) vaccine candidate designed for the prevention of influenza. Developed by VLP Therapeutics, the vaccine utilizes the company's proprietary VLP platform to present influenza virus antigens to the immune system. VLPs are non-infectious protein assemblies that mimic the structure of the native virus but lack the viral genome, allowing for the safe induction of potent neutralizing antibody and cellular immune responses. This platform is intended to provide a highly organized, repetitive display of antigens to enhance immunogenicity. As of late 2025, the candidate is in the preclinical stage of development.
- Other names
- VLP influenza vaccine
02
Targets
Flu (Influenza surface proteins)
Beyond the preview
Go deeper on Influenza Vaccine (VLP Therapeutics).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza Vaccine (VLP Therapeutics).